Search

everythinglearnresearchcommunity

for

Search:↓

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Genetics influence opioid addiction risk, diet affects COVID-19 severity, Aerva lanata may harm kidneys, some plants fight fungi and cancer, and nursing students need better contraceptive knowledge.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Certain proteins, Lgr5 and Lgr6, are important markers of adult stem cells and are involved in tissue repair and cancer development.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Anti-angiogenic therapy can help treat cancer but may cause resistance and side effects, so alternative methods are being explored.

Cancer risk is linked to the balance of mutations and environmental factors, not just the number of mutations.

Further research is needed to develop effective cancer prevention strategies.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

The ITGB6 gene is important for tissue repair and hair growth, and mutations can lead to enamel defects and other health issues.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Early screening and HPV vaccination reduce cervical cancer risk.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Breast pain is common and usually not linked to cancer, with treatment varying by severity.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

The investigation found no work-related causes for employee hair loss at Equifax Payment Services, and the environment was not hazardous.

DKK proteins could help diagnose and treat various non-cancerous diseases.

Testosterone pellets may help women's sexual function but have safety concerns and need more research.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.